|
US10266585B2
(en)
*
|
2009-08-28 |
2019-04-23 |
The Board Of Regents Of The Univerity Of Texas System |
Methods of treating brain injury
|
|
US10130697B2
(en)
|
2010-03-23 |
2018-11-20 |
Wisconsin Alumni Research Foundation (Warf) |
Vaccines comprising mutant attenuated influenza viruses
|
|
MY164376A
(en)
*
|
2010-10-07 |
2017-12-15 |
Univ Leuven Kath |
Phosphospecific antibodies recognizing tau
|
|
CA2813493C
(en)
|
2010-10-11 |
2019-07-09 |
University Of Zurich |
Human anti-tau antibodies
|
|
US20120244174A1
(en)
|
2011-01-31 |
2012-09-27 |
Intellect Neurosciences Inc. |
Treatment of tauopathies
|
|
GB201112056D0
(en)
*
|
2011-07-14 |
2011-08-31 |
Univ Leuven Kath |
Antibodies
|
|
US10813630B2
(en)
|
2011-08-09 |
2020-10-27 |
Corquest Medical, Inc. |
Closure system for atrial wall
|
|
US10314594B2
(en)
|
2012-12-14 |
2019-06-11 |
Corquest Medical, Inc. |
Assembly and method for left atrial appendage occlusion
|
|
US10307167B2
(en)
|
2012-12-14 |
2019-06-04 |
Corquest Medical, Inc. |
Assembly and method for left atrial appendage occlusion
|
|
JP2014527799A
(ja)
|
2011-08-26 |
2014-10-23 |
ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション |
変異型ｐｂ２遺伝子セグメントを有する弱毒化生ワクチンとしてのインフルエンザウイルス
|
|
KR101981351B1
(ko)
|
2011-10-07 |
2019-09-02 |
에이씨 이뮨 에스.에이. |
타우를 인식하는 포스포특이적 항체
|
|
MX350311B
(es)
|
2011-12-20 |
2017-09-01 |
Janssen Biotech Inc |
Anticuerpos anti-phf-tau y sus usos.
|
|
RU2644242C2
(ru)
*
|
2012-04-05 |
2018-02-08 |
Ац Иммуне С.А. |
Гуманизированное тау-антитело
|
|
SG10201708959WA
(en)
*
|
2012-07-03 |
2017-11-29 |
Univ Washington |
Antibodies to tau
|
|
WO2014016737A1
(en)
*
|
2012-07-24 |
2014-01-30 |
Pfizer Inc. |
Novel chicken monoclonal antibodies against human phosphorylated tau and uses thereof
|
|
NZ630542A
(en)
|
2012-08-16 |
2017-06-30 |
Ipierian Inc |
Methods of treating a tauopathy
|
|
US12024568B2
(en)
|
2012-09-13 |
2024-07-02 |
Cornell University |
Treatment of brain cancers using central nervous system mediated gene transfer of monoclonal antibodies
|
|
US20140142689A1
(en)
|
2012-11-21 |
2014-05-22 |
Didier De Canniere |
Device and method of treating heart valve malfunction
|
|
CA2896066C
(en)
|
2012-12-21 |
2022-07-12 |
Biogen Ma Inc. |
Human anti-tau antibodies
|
|
US8980270B2
(en)
|
2013-01-18 |
2015-03-17 |
Ipierian, Inc. |
Methods of treating a tauopathy
|
|
WO2014150877A2
(en)
|
2013-03-15 |
2014-09-25 |
Ac Immune S.A. |
Anti-tau antibodies and methods of use
|
|
SG11201509982UA
(cg-RX-API-DMAC7.html)
*
|
2013-06-06 |
2016-04-28 |
Igenica Biotherapeutics Inc |
|
|
GB201312226D0
(en)
*
|
2013-07-08 |
2013-08-21 |
Adx Neurosciences |
Improved antibodies
|
|
US9566443B2
(en)
|
2013-11-26 |
2017-02-14 |
Corquest Medical, Inc. |
System for treating heart valve malfunction including mitral regurgitation
|
|
BR112016010454A2
(pt)
*
|
2013-11-27 |
2017-12-05 |
Ipierian Inc |
métodos para tratar uma taupatia
|
|
AU2014368696A1
(en)
|
2013-12-20 |
2016-06-02 |
F. Hoffmann-La Roche Ag |
Humanized anti-Tau(pS422) antibodies and methods of use
|
|
JP2017512751A
(ja)
|
2014-02-14 |
2017-05-25 |
アイピエリアン，インコーポレイティド |
タウペプチド、抗タウ抗体、およびそれらの使用方法
|
|
US10053671B2
(en)
|
2014-06-20 |
2018-08-21 |
Wisconsin Alumni Research Foundation (Warf) |
Mutations that confer genetic stability to additional genes in influenza viruses
|
|
AR100978A1
(es)
|
2014-06-26 |
2016-11-16 |
Hoffmann La Roche |
LANZADERAS CEREBRALES DE ANTICUERPO HUMANIZADO ANTI-Tau(pS422) Y USOS DE LAS MISMAS
|
|
TWI734975B
(zh)
|
2014-06-27 |
2021-08-01 |
美商Ｃ２Ｎ醫療診斷有限責任公司 |
人類化抗-tau抗體
|
|
WO2016054247A1
(en)
|
2014-09-30 |
2016-04-07 |
Washington University |
Tau kinetic measurements
|
|
CN107428820B
(zh)
*
|
2014-11-19 |
2022-03-22 |
阿克松神经系统科学公司 |
在阿尔茨海默氏病中的人源化tau抗体
|
|
US10842626B2
(en)
|
2014-12-09 |
2020-11-24 |
Didier De Canniere |
Intracardiac device to correct mitral regurgitation
|
|
TWI669314B
(zh)
|
2015-02-26 |
2019-08-21 |
美國禮來大藥廠 |
針對ｔａｕ之抗體及其用途
|
|
NZ775762A
(en)
|
2015-06-05 |
2025-02-28 |
Genentech Inc |
Anti-tau antibodies and methods of use
|
|
WO2016207245A1
(en)
|
2015-06-24 |
2016-12-29 |
F. Hoffmann-La Roche Ag |
Humanized anti-tau(ps422) antibodies and methods of use
|
|
WO2017005734A1
(en)
|
2015-07-06 |
2017-01-12 |
Ucb Biopharma Sprl |
Tau-binding antibodies
|
|
JO3711B1
(ar)
*
|
2015-07-13 |
2021-01-31 |
H Lundbeck As |
أجسام مضادة محددة لبروتين تاو وطرق استعمالها
|
|
WO2017027691A1
(en)
|
2015-08-13 |
2017-02-16 |
New York University |
Antibody-based molecules selective for the {p}ser404 epitope of tau and their uses in the diagnosis and treatment of tauopathy
|
|
US11197925B2
(en)
|
2016-02-19 |
2021-12-14 |
Wisconsin Alumni Research Foundation (Warf) |
Influenza B virus replication for vaccine development
|
|
PH12018502613B1
(en)
|
2016-07-12 |
2023-02-01 |
H Lundbeck As |
Antibodies specific for hyperphosphorylated tau and methods of use thereof
|
|
CA3032692A1
(en)
|
2016-08-09 |
2018-02-15 |
Eli Lilly And Company |
Combination antibody therapy for the treatment of neurodegenerative diseases
|
|
MX2019006330A
(es)
|
2016-12-07 |
2019-09-26 |
Genentech Inc |
Anticuerpos anti-tau y metodos de uso.
|
|
UA128383C2
(uk)
*
|
2016-12-07 |
2024-07-03 |
Дженентек, Інк. |
Антитіло до тау-білка та спосіб його застосування
|
|
CN110267985B
(zh)
*
|
2017-01-04 |
2023-05-23 |
H.隆德贝克有限公司 |
用于治疗眼科疾病的特异性针对过度磷酸化τ蛋白的抗体
|
|
SG11201907422RA
(en)
|
2017-02-17 |
2019-09-27 |
Denali Therapeutics Inc |
Anti-tau antibodies and methods of use thereof
|
|
JP2018139530A
(ja)
|
2017-02-27 |
2018-09-13 |
帝人ファーマ株式会社 |
認知症治療又は予防のためのヒト化抗体及びその製造方法、並びにそれを用いた認知症治療剤又は予防剤
|
|
EA039569B1
(ru)
*
|
2017-03-14 |
2022-02-11 |
Х. Лундбекк А/С |
Антитела, специфичные к гиперфосфорилированному тау-белку, и способы их применения
|
|
TWI771389B
(zh)
|
2017-03-16 |
2022-07-21 |
美商健生生物科技公司 |
抗phf-tau抗體及其用途
|
|
WO2018217630A1
(en)
*
|
2017-05-21 |
2018-11-29 |
University Of Tennessee Research Foundation |
Methods and compositions for targeting tissue lesions
|
|
AU2018352308B2
(en)
|
2017-10-16 |
2025-06-05 |
Eisai R&D Management Co., Ltd. |
Anti-tau antibodies and uses thereof
|
|
WO2019084310A1
(en)
|
2017-10-25 |
2019-05-02 |
Yoshihiro Kawaoka |
HAS RECOMBINANT INFLUENZA VIRUSES STABILIZED FOR EGG REPLICATION
|
|
EP3718462A4
(en)
*
|
2017-11-28 |
2021-08-18 |
Mie University |
PROOF PROCEDURE
|
|
CA3093200A1
(en)
|
2018-03-05 |
2019-09-12 |
Janssen Pharmaceutica Nv |
Anti-phf-tau antibodies and uses thereof
|
|
CA3107788A1
(en)
|
2018-07-31 |
2020-02-06 |
Eli Lilly And Company |
Combination of anti-tau antibody and oga inhibitor for treatment of diseases characterized by aberrant tau aggregation
|
|
US12343390B2
(en)
|
2018-08-07 |
2025-07-01 |
Wisconsin Alumni Research Foundation (Warf) |
Recombinant biologically contained filovirus vaccine
|
|
JP7655849B2
(ja)
|
2018-08-20 |
2025-04-02 |
ウィスコンシン アルムニ リサーチ ファンデイション |
ヘマグルチニン（ｈａ）タンパク質内の非ドミナントエピトープに対する免疫応答を誘起するためのベクター
|
|
US12116415B2
(en)
*
|
2018-10-09 |
2024-10-15 |
Single Cell Technology, Inc. |
Anti-BCMA antibodies
|
|
WO2020077380A1
(en)
*
|
2018-10-17 |
2020-04-23 |
The University Of Queensland |
Methods and compositions for treating tauopathies
|
|
CA3118692A1
(en)
|
2018-11-06 |
2020-05-14 |
Alsatech, Inc. |
Cell-based gene therapy for neurodegenerative diseases
|
|
EP3906055A4
(en)
*
|
2019-01-04 |
2023-01-04 |
Trio Pharmaceuticals, Inc. |
MULTISPECIFIC PROTEIN MOLECULES AND THEIR USES
|
|
EP3921413A1
(en)
|
2019-02-08 |
2021-12-15 |
Wisconsin Alumni Research Foundation (WARF) |
Humanized cell line
|
|
WO2020201828A1
(en)
|
2019-04-05 |
2020-10-08 |
Tauc3 Biologics Limited |
Anti-tauc3 antibodies and uses thereof
|
|
SG11202109051PA
(en)
*
|
2019-04-12 |
2021-10-28 |
Phanes Therapeutics Inc |
Humanized anti-folate receptor 1 chimeric antigen receptors and uses thereof
|
|
CN114929269A
(zh)
|
2019-05-01 |
2022-08-19 |
威斯康星校友研究基金会(Warf) |
用于疫苗开发的改进的流感病毒复制
|
|
CN110028583B
(zh)
*
|
2019-05-07 |
2020-09-11 |
温州医科大学 |
抗Tau抗体及其在治疗阿尔茨海默病、创伤性脑损伤中的应用
|
|
US11807872B2
(en)
|
2019-08-27 |
2023-11-07 |
Wisconsin Alumni Research Foundation (Warf) |
Recombinant influenza viruses with stabilized HA for replication in eggs
|
|
CN112752251B
(zh)
*
|
2019-10-29 |
2022-05-06 |
中国移动通信有限公司研究院 |
一种ue标识符的分配方法、装置和计算机可读存储介质
|
|
JP2023511444A
(ja)
|
2020-01-24 |
2023-03-17 |
ウィスコンシン アルムニ リサーチ ファンデイション |
安定化されたｎａを有する組換えインフルエンザウイルス
|
|
CN115066610A
(zh)
*
|
2020-02-05 |
2022-09-16 |
住友制药株式会社 |
用于tau病变和痴呆相关疾病的确定试剂和确定方法
|
|
WO2021195410A1
(en)
|
2020-03-25 |
2021-09-30 |
Wisconsin Alumni Research Foundation (Warf) |
Recombinant multivalent influenza viruses
|
|
CA3183835A1
(en)
|
2020-06-25 |
2021-12-30 |
Jeanne E. Baker |
High affinity antibodies targeting tau phosphorylated at serine 413
|
|
EP4014997A1
(en)
|
2020-12-16 |
2022-06-22 |
Consejo Superior de Investigaciones Científicas (CSIC) |
Stard1 inhibitors for the treatment of lysosomal disorders
|
|
CN117043183A
(zh)
*
|
2020-12-16 |
2023-11-10 |
沃雅戈治疗公司 |
Tau结合化合物
|
|
TW202300172A
(zh)
*
|
2021-03-18 |
2023-01-01 |
美商思進公司 |
抗alpp/alppl2抗體及抗體藥物結合物
|
|
CL2021001380A1
(es)
|
2021-05-26 |
2022-01-14 |
Corporacion Centro Int De Biomedicina Icc |
Generación de un nuevo anticuerpo monoclonal sitio específico para la proteína tau y su uso como herramienta en biomarcadores específicos para la detección temprana de enfermedades neurodegenerativas y patologías involucradas con la proteína tau como alzheimer y otras demencias.
|
|
US20250034559A1
(en)
|
2021-11-17 |
2025-01-30 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of tau-related disorders
|
|
KR20250069606A
(ko)
|
2022-09-15 |
2025-05-19 |
보이저 테라퓨틱스, 인크. |
타우 결합 화합물
|
|
WO2024163923A2
(en)
*
|
2023-02-02 |
2024-08-08 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Phosphomimetic mutants, phosphospecific antibodies, and uses thereof
|
|
WO2025122634A1
(en)
|
2023-12-05 |
2025-06-12 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of tau-related disorders
|
|
WO2025128975A1
(en)
*
|
2023-12-14 |
2025-06-19 |
Immunitas Therapeutics, Inc. |
Cd161 binding proteins and related methods
|
|
WO2025134068A1
(en)
|
2023-12-22 |
2025-06-26 |
Ac Immune Sa |
Antibody drug conjugates targeting proteinopathies, and uses thereof
|